Nureca Limited (NURECA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nureca Limited (NURECA) has a cash flow conversion efficiency ratio of 0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs44.46 Million ≈ $480.82K USD) by net assets (Rs1.99 Billion ≈ $21.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Nureca Limited to measure how many days the company can operate on defensive assets alone.
Nureca Limited - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Nureca Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nureca Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nureca Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tvardi Therapeutics, Inc.
NASDAQ:TVRD
|
-0.404x |
|
Vikas EcoTech Limited
NSE:VIKASECO
|
-0.032x |
|
Castec Korea Co Ltd
KQ:071850
|
0.104x |
|
Aquarius Engines AM Ltd
TA:AQUA
|
-32.231x |
|
Jeongsan Aikang Co.Ltd
KQ:022220
|
0.002x |
|
FIGENE CAPITAL SA ZY 1
F:20X
|
N/A |
|
YoungWoo DSP Co.Ltd
KQ:143540
|
0.289x |
|
Omnisystem Co.Ltd
KQ:057540
|
0.039x |
Annual Cash Flow Conversion Efficiency for Nureca Limited (2017–2025)
The table below shows the annual cash flow conversion efficiency of Nureca Limited from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see NURECA market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs1.94 Billion ≈ $21.01 Million |
Rs-190.83 Million ≈ $-2.06 Million |
-0.098x | -599.40% |
| 2024-03-31 | Rs1.93 Billion ≈ $20.88 Million |
Rs-27.12 Million ≈ $-293.29K |
-0.014x | -126.76% |
| 2023-03-31 | Rs1.95 Billion ≈ $21.08 Million |
Rs102.27 Million ≈ $1.11 Million |
0.052x | +662.22% |
| 2022-03-31 | Rs2.03 Billion ≈ $21.98 Million |
Rs13.99 Million ≈ $151.30K |
0.007x | -96.78% |
| 2021-03-31 | Rs1.63 Billion ≈ $17.64 Million |
Rs348.67 Million ≈ $3.77 Million |
0.214x | +140.30% |
| 2020-03-31 | Rs149.34 Million ≈ $1.62 Million |
Rs-79.23 Million ≈ $-856.84K |
-0.531x | -1581.51% |
| 2019-03-31 | Rs85.45 Million ≈ $924.11K |
Rs3.06 Million ≈ $33.09K |
0.036x | -37.78% |
| 2018-03-31 | Rs17.20 Million ≈ $186.01K |
Rs990.00K ≈ $10.71K |
0.058x | +106.30% |
| 2017-03-31 | Rs102.45K ≈ $1.11K |
Rs-93.62K ≈ $-1.01K |
-0.914x | -- |
About Nureca Limited
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, p… Read more